載入...
Mortality Risk of Darbepoetin Alfa versus Epoetin Alfa in Patients with Chronic Kidney Disease: Systematic Review and Meta-Analysis
BACKGROUND: Epoetin alfa (EPO) and darbepoetin alfa (EPO) are erythropoiesis-stimulating agents that are widely and interchangeably used for the treatment of anemia in patients with advanced chronic kidney disease and end-stage renal disease. No studies have specifically compared the risks of hard s...
Na minha lista:
| 發表在: | Am J Kidney Dis |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485593/ https://ncbi.nlm.nih.gov/pubmed/25636816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2014.12.012 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|